...
首页> 外文期刊>BMC Biotechnology >Lentivirus expressing shRNAs inhibit the replication of contagious ecthyma virus by targeting DNA polymerase gene
【24h】

Lentivirus expressing shRNAs inhibit the replication of contagious ecthyma virus by targeting DNA polymerase gene

机译:表达SHRNA的慢病毒通过靶向DNA聚合酶基因抑制传染性异位病毒的复制

获取原文
           

摘要

Contagious ecthyma or Orf is known as a zoonotic disease remains prevalently worldwide despite the application of some control strategies against it. RNAi particularly shRNA provides us with the chance to tackle this obstacle by an encouraging new approach. The current study indicates the design and experiment of third-generation lentivirus packaging systems delivering shRNAs to inhibit Orf virus (ORFV) replication and infection. Given the importance of DNA-pol gene in virus replication, in this study, three shRNAs against this gene were designed and cloned into lentiviral vectors to stabilize the expression of shRNAs. After producing lentivectors expressing ORFV-DNA– pol in HEK293T cells, the synthesized shRNAs were applied to downregulate viral replication and gene expression. The reduction in viral titer and RNA was evaluated by TCID50 test as well as real-time RT-PCR. The results were then analyzed in comparison with the control group. Designed shRNAs significantly reduced virus yield approximately 90 to 97% and 96.8 to 99.4%, respectively compared to the control groups (cells infected with ORFV and infected with ORFV and scrambled vector) by TCID50 test. Real-time RT-PCR revealed a dramatic reduction in the expression of viral RNA approximately 99% compared to cells infected with ORFV and from 92.6 to 99%, respectively compared to cells infected with ORFV and scrambled vector. Therefore, it can be stated that RNAi is capable of being used as a potent therapeutically option against viruses like ORFV.
机译:虽然存在一些控制策略,但患有传染病患者或ORF被称为人群疾病仍然存在普遍存在的疾病。 RNAi特别是Shrna为我们提供了通过鼓励的新方法来解决这个障碍的机会。目前的研究表明,第三代Lentivirus包装系统的设计和实验,递送SHRNA抑制ORF病毒(ORFV)复制和感染。鉴于DNA-POL基因在病毒复制中的重要性,在本研究中,设计并克隆到慢病毒载体中的三个SHRNA,以稳定SHRNA的表达。在生产HEK293T细胞中表达ORFV-DNA-POL的慢动病术后,将合成的SHRNA应用于下调病毒复制和基因表达。通过TCID50测试和实时RT-PCR评估病毒滴度和RNA的还原。然后与对照组相比分析结果。与对照组(用orfv感染的细胞和orfv和糖浆和加扰载体感染的细胞和糖浆和糖浆和加扰载体感染的细胞和orfv和糖浆和加扰载体感染的细胞和orfv和糖浆和糖浆和糖浆载体感染的细胞和orfv和糖浆和炒载体感染的细胞)显着降低病毒产生约90%至97%和96.8%至99.4%。实时RT-PCR揭示了病毒RNA表达的显着降低了约99%,与用orfv感染的细胞和92.6%至99%相比,与感染的orfv和炒载体的细胞相比。因此,可以说RNAi能够用作逆毒等病毒的有效治疗选择。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号